| Name | Ezetimibe Hydroxy β-D-Glucuronide |
|---|---|
| Synonyms | (2S,3S,4S,5R,6R)-6-[(1S)-1-(4-fluorophenyl)-3-[(2S,3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxoazetidin-3-yl]propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
| Description | Ezetimibe hydroxy glucuronide (SCH 488128) is a trace metabolite detected in dog and human plasma samples after oral administration of Ezetimibe (HY-17376)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.547g/cm3 |
|---|---|
| Boiling Point | 863.74ºC at 760 mmHg |
| Melting Point | 127-129ºC |
| Molecular Formula | C30H29F2NO9 |
| Molecular Weight | 585.55 |
| Flash Point | 476.173ºC |
| Exact Mass | 585.18100 |
| PSA | 156.99000 |
| LogP | 2.86980 |
| Index of Refraction | 1.68 |